ALLERGAN INC. v. APOTEX INC. ET AL.
Summary of T-1315-19
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: Patented Medicines (NOC) Regulations [Actions]
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| ALLERGAN INC | McCarthy Tétrault LLP TOR | TANNER, STEVEN |
| ALLERGAN INC | ||
| APOTEX INC | ||
| THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEA |
| Name | Number |
|---|---|
| FIBRISTAL | |
| 2713254 |
Patented Medicine: Ulipristal (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| Allergan Inc. v. Apotex Inc. 2019 FC 1659 | Dec 23, 2019 | This is a motion brought by the co-owner of the patent, The USA, for an Order allowing the USA leave to file a responding pleading to Apotex’ Statement of Defence. The underlying proceeding is an action brought under s. 6(1) of the Amended PM(NOC) Regulations in which Allergan Inc. (acting under the consent of the patent owners) seeks a declaration of infringement in respect of Canadian Patent No. 2,713,254 (the “254 Patent”). In response to the action, Apotex has filed a Statement of Defence asserting that the 254 Patent is invalid on a number of grounds. The USA was named as a party Defendant to the proceeding pursuant to s. 6(2) of the PM(NOC) Regulations. ... Its interest, as expressed at the motion, is solely to address the validity allegations made in Apotex’ Statement of Defence. ... In my view, the USA’s pleading should be identified as what it is: a Reply to the Statement of Defence. ... The role of the USA in the proceeding shall be limited to participating on the issues arising from the USA’s Reply, namely to responding to Apotex’ invalidity allegations and seeking to uphold the validity of the 254 Patent; and shall not be duplicative of the role of Allergan. |
| Allergan Inc. v. Apotex Inc. 2020 FC 658 | Jun 1, 2020 | This motion brought by Apotex seeks various relief relating to discovery of the patentees, HRA and USA, and of inventors of the 254 Patent and the 084 Patent, including with respect to the use that can be made of such discovery. ... To date, the Defendant HRA, who is based in France, has taken no active role in the proceedings and has not attorned to the jurisdiction of this Court. ... Where it is clear that a commercial relationship exists and that the formal requirements to obtain discovery of an inventor in Europe could be avoided, the most practical solution, in line with rule 3 of the Federal Court Rules and section 6.09 of the PMNOC Regulations, is for Allergan to use its best efforts to obtain the participation of Dr. Gainer or another HRA witness with knowledge. |
Docket Summary (Google Translate to English)
(44) 2020-09-15 - TorontoSolicitor's certificate of service on behalf of Bohanda Tkachuk confirming service of Doc.NO. 43 upon Defendant and Patent Owner/Licensee by email on 15-SEP-2020 filed on 15-SEP-2020
Discontinuance on behalf of Plaintiff filed on 15-SEP-2020
Acknowledgment of Receipt received from all parties with respect to Doc. 42 placed on file on 11-SEP-2020
AMENDED SCHEDULING ORDER dated 11-SEP-2020 rendered by Angela Furlanetto, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: granted Filed on 11-SEP-2020 copies sent to parties entered in J. & O. Book, volume 1463 page(s) 95 - 97 Interlocutory Decision
Toronto 10-SEP-2020 BEFORE Angela Furlanetto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: motions to compel to be heard on 22-OCT-2020, 9:30 a.m. for 1d by way of Zoom video. held by way of Conference Call in chambers Duration per day: 10-SEP-2020 from 10:00 to 10:26 Courtroom : Judge's Chambers - Toronto Court Registrar: Jake Schutz Total Duration: 26min Appearances: Ms. Tkachuk and Ms. Templer n/a representing Plaintiff Mr. Naiberg n/a representing Defendant Mr. Crandell n/a representing Patentee/Owner United States of America Minutes of Hearing entered in Vol. 1049 page(s) 255 - 255 Abstract of Hearing placed on file
Letter from Defendant dated 04-SEP-2020 re: status update and dates of availability for a CMC received on 04-SEP-2020
Successful email transmission received from the parties with respect to order ID 109 placed on file on 21-AUG-2020
Amended scheduling order dated 21-AUG-2020 rendered by Angela Furlanetto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 20-AUG-2020 Result: granted Filed on 21-AUG-2020 copies sent to parties entered in J. & O. Book, volume 1461 page(s) 340 - 343 Interlocutory Decision
Letter from Plaintiff dated 20-AUG-2020 on consent attaching proposed schedule for this action received on 20-AUG-2020
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 14-AUG-2020 directing that "Further to the letter dated July 29, 2020 sent on behalf of the parties, the parties shall provide the Court with a further status update, their proposed revised timetable and shall advise if a case management conference is necessary, along with their availability, by August 20, 2020." placed on file on 14-AUG-2020
Certified French language Translation of Reasons for Order and Order rendered on 01-JUN-2020 by Angela Furlanetto, Prothonotary filed on 31-JUL-2020 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Order entered in J. & O. Book, volume 1459 page(s) 429 - 431 and copy placed on file.
Letter from Plaintiff dated 29-JUL-2020 providing an update to the status of the proceeding received on 29-JUL-2020
Toronto 25-JUN-2020 BEFORE Angela Furlanetto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Parties discuss the issue of privilege held by way of Conference Call Duration per day: 25-JUN-2020 from 02:00 to 02:33 Courtroom : Judge's Chambers - Toronto Court Registrar: Andrew Murray Total Duration: 33min Appearances: Deborah Templer 416-601-8421 representing Plaintiff Sanjaya Mendis 416-601-8421 representing Plaintiff Andrew Brodkin 416-979-2211 representing Defendant Richard Naiberg 416-979-2211 representing Defendant Marc Crandall 613-783-8984 representing Defendant Comments: DARS not used. The parties discuss the ongoing issue of privilege and work out an alternative, and might possibly be sending in a modified schedule. Minutes of Hearing entered in Vol. 1046 page(s) 43 - 44 Abstract of Hearing placed on file
Letter from Plaintiff dated 24-JUN-2020 This letter is in response to Apotex's letter of June 23rd, and reasserts that they have provided the defendant's with everything in their power.. etc received on 24-JUN-2020
Letter from Defendant dated 22-JUN-2020 This letter is in regards to the issue of privilege and address the details provided in the June 18th letter from the plaintiff. received on 23-JUN-2020
Letter from Plaintiff dated 18-JUN-2020 This letter is in regards to the issue of privilege that has occured in this matter. (CONFIDENTIAL) received on 18-JUN-2020
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 18-JUN-2020 directing that "Further to the case management conference convened on June 18, 2020, the Court directs that: 1)Allergan shall provide by end of day on June 18, 2020 the following further information regarding each of the privileged documents in its further affidavit of documents as relating to paragraph 3(b) of the Court's June 1, 2020 Order (i) identification of the sender/recipient (ii)date of the document (iii)description of the document and nature of the information to provide context for the privilege claimed, and (iv)category of privilege asserted; 2)Apotex shall advise by end of day on June 22, 2020 whether it intends to challenge the privilege and if so, the proposed manner for dealing with the challenge and timing and shall identify any other issues for discussion at the follow-up case management conference; and 3)a further case management conference will be convened on June 25, 2020 at 2pm to discuss this issue as well as any anticipated amendments to the schedule for these actions" placed on file on 18-JUN-2020
Toronto 18-JUN-2020 BEFORE Angela Furlanetto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Parties discuss the privilege issue and set another CMC down for June 25th @ 2pm held by way of Conference Call Duration per day: 18-JUN-2020 from 09:00 to 09:52 Courtroom : Judge's Chambers - Toronto Court Registrar: Andrew Murray Total Duration: 52min Appearances: Sanjaya Mendis 416-601-8421 representing Plaintiff Deborah Templer 416-601-8421 representing Plaintiff Andrew Brodkin 416-597-4278 representing Defendant Richard Naiberg 416-597-4278 representing Defendant Marc Crandall 613-783-8984 representing Defendant Comments: DARS not used. The parties discuss the issue of privilege and agree to have another CMC on June 25th @ 2pm Minutes of Hearing entered in Vol. 1045 page(s) 338 - 339 Abstract of Hearing placed on file
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 16-JUN-2020 directing that a case management teleconference shall take place on Thursday, June 18, 2020 at 9AM placed on file on 16-JUN-2020
Letter from Plaintiff dated 16-JUN-2020 providing the parties' availability for a case management conference received on 16-JUN-2020
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 15-JUN-2020 directing that "The parties shall provide the Court with a further update by end of day on June 17, 2020 as to whether the matters raised by counsel for Apotex has been resolved and if not, shall provide their joint availability for a case management teleconference to be convened on either June 18 or 19." placed on file on 15-JUN-2020
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 08-JUN-2020 directing that "The court is in receipt of the parties' letter from June 4, June 5 and June 8 related to paragraph 3(c) of the order issued on June 1, 2020. In accordance with the Court's order. Allergan is to update its affidavit of documents and productions to include all relevant documents that have come into Allergan's possession and control from HRA. In the context of Apotex's motion and the proceedings this is all documents Allergan received from HRA pertaining to ulipristal acetate and the development work underlying Canadian Patent Nos. 2,713,254 and 2,745,084 or their foreign counterparts. This may be a subset of the full database delivered by HRA to Allergan. The Court has made no findings as to the full contents of what was included in that database. Should there be any issue relating to the sufficiency of production after discovery of Dr. Gainer and Allergan, Apotex may raise this issue further at that time." placed on file on 08-JUN-2020
Letter from Plaintiff dated 08-JUN-2020 This letter is in response to the defendant's letter of June 5th. received on 08-JUN-2020
Letter from Plaintiff dated 05-JUN-2020 in response to the Defendant's (Apotex Inc.) letter dated 4-JUN-2020 received on 05-JUN-2020
Letter from Defedant Apotex Inc. dated 04-JUN-2020 seeking direction in regards to a dispute between the Plaintiff and Defendant Apotex over the meaning of the Court's Order and Reasons dated June 1, 2020 received on 04-JUN-2020
Acknowledgment of Receipt received from the Plaintiff and Defendants with respect to Doc. 39 placed on file on 02-JUN-2020
Certificate of Order with respect to the Order and Reasons (Doc. 39) placed on file on 01-JUN-2020
Reasons for Order and Order dated 01-JUN-2020 rendered by Angela Furlanetto, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 29 Result: granted in part Filed on 01-JUN-2020 copies sent to parties Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1454 page(s) 463 - 464
Toronto 06-MAY-2020 BEFORE Angela Furlanetto, Prothonotary Language: E Before the Court: Motion Doc. No. 29 on behalf of Defendant Result of Hearing: Matter reserved held by way of video conference Duration per day: 06-MAY-2020 from 09:30 to 11:50 Courtroom : Judge's Chambers - Toronto Court Registrar: Cherlin McColman Total Duration: 2h 20min Appearances: Mr. Steven Tanner 416-601-8160 representing Plaintiff Ms. Bohdana Tkachuk 416-601-8160 representing Plaintiff Ms. Deborah Templer 416-601-8421 representing Plaintiff Mr. Andrew Brodkin 416-597-4278 representing Defendant Mr. Richard Naiberg 416-597-4247 representing Defendant Mr. Marc Crandall 613-783-8984 representing Defendnat/Patent Owner, United States of America Comments: Tascam Recorder used to record hearing. Minutes of Hearing entered in Vol. 1044 page(s) 93 - 96 Abstract of Hearing placed on file
Toronto 30-APR-2020 BEFORE Angela Furlanetto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the Court will issue a direction from decision made in the CMC held by way of Conference Call Duration per day: 30-APR-2020 from 10:00 to 10:15 Courtroom : Judge's Chambers - Toronto Court Registrar: Shaun Nelson Total Duration: 15min Appearances: Mr. Tanner, Mr. Mendis 416-601-8193 representing Plaintiff Mr. Brodkin, Mr. Naiberg 416-597-4278 representing Defendant Mr. Crandall 613-558-3287 representing USA Minutes of Hearing entered in Vol. 1044 page(s) 73 - 74 Abstract of Hearing placed on file
Letter from Defendant dated 04-MAY-2020 enclosing the answers to the written cross-examination of Lisa Ebdon, attached as Exhibit "A" received on 04-MAY-2020
Order dated 30-APR-2020 rendered by Angela Furlanetto, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: Amended Scheduling Order granted Filed on 30-APR-2020 certified copies sent to parties entered in J. & O. Book, volume 1452 page(s) 250 - 253 Interlocutory Decision
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 30-APR-2020 directing that further to the case management conference convened on 30-APR-2020, the Court directs that the answers to the written cross-examination of the defendant Apotex' affiant on the motion to be heard on 6-MAY-2020 may be provided by way of letter and shall be served and filed by 4-MAY-2020 placed on file on 30-APR-2020
Letter from Plaintiff dated 30-APR-2020 providing an updated timetable setting out the proposed revisions for the steps set out in the Court's October 7, 2019 Order (attached as Schedule "A") received on 30-APR-2020
Solicitor's certificate of service on behalf of Steve Tanner confirming service of Doc. 36 and the Book of Authorities upon Defendant by email on 27-APR-2020 filed on 27-APR-2020
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 27-APR-2020
Written Representations (Responding) on behalf of Plaintiff concerning Motion Doc. No. 29 filed on 27-APR-2020
Solicitor's certificate of service on behalf of Marc Crandall confirming service of Doc. 34 upon Plaintiff by email on 27-APR-2020 confirming service Doc. 34 upon Defendant by email on 27-APR-2020 filed on 27-APR-2020
Motion Record in response to Motion Doc. No. 29 containing the following original document(s): 33 Number of copies received: 3 on behalf of Defendant/Patentee, The United States of America filed on 27-APR-2020
Written Representations contained within a Motion Record on behalf of Defendant/Patentee, The United States of America concerning Motion Doc. No. 29 filed on 27-APR-2020
Motion Record containing the following original document(s): 29 30 31 Number of copies received: 3 on behalf of Defendant filed on 17-APR-2020
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 29 filed on 17-APR-2020
Affidavit of Lisa Ebdon sworn on 17-APR-2020 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 29 with Exhibits A-Q filed on 17-APR-2020
Notice of Motion contained within a Motion Record on behalf of Defendant returnable at Special Sitting in Toronto on 06-MAY-2020 to begin at 10:00 for Productions filed on 17-APR-2020
Letter from Defendant dated 17-APR-2020 covering letter for motion record received on 17-APR-2020
Toronto 08-APR-2020 BEFORE Angela Furlanetto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: matter will reconvene 30-APR-2020 to discuss the motion scheduled 6-MAY-2020 held by way of Conference Call Duration per day: 08-APR-2020 from 11:00 to 11:20 Courtroom : Judge's Chambers - Toronto Court Registrar: Shaun Nelson Total Duration: 20min Appearances: Mr. Tanner, Mr. Mendis 416-601-8193 representing Plaintiff Mr. Brodkin, Mr. Nieberg 416-597-4278 representing Defendant Mr. Crandall 613-558-3287 representing USA Minutes of Hearing entered in Vol. 1043 page(s) 299 - 300 Abstract of Hearing placed on file
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 08-APR-2020 directing that Further to the Case Management Conference convened on April 8, 2020, the Court directs as follows: 1) the parties shall provide an updated timetable setting out their proposed revisions for the steps set out in the Court's October 7, 2019 Order; 2) the following timing shall apply to the defendant's motion relating to the discovery issues set out in it's April 7, 2020 letter ; a) the Defendant shall serve and file it's motion record by April 17, 2020; b) all responding motion records shall be served and filed by April 27, 2020; c)a further case management conference shall be convened on April 30, 2020 commencing at 10AM; d) the motion shall be heard on May 6, 2020 by videoconference, commencing at 9:30am. Further details for the motion shall be confirmed at the case management conference on April 30, 2020. All motion records are to be filed electronically in accordance with the Court's practice direction and Order dated April 4, 2020 relating to COVID-19 placed on file on 08-APR-2020
Letter from Plaintiff dated 08-APR-2020 in response to the Defendant's letter dated April 7, 2020 with attached case law received on 08-APR-2020
Letter from Defendant dated 07-APR-2020 outlining issues to be raised at the case management teleconference scheduled for April 8, 2020 received on 07-APR-2020
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 06-APR-2020 directing that a case management teleconference shall take place on Wednesday, April 8, 2020 at 11:00 AM placed on file on 06-APR-2020
Letter from Plaintiff dated 03-APR-2020 providing an update as to the status of the proceedings received on 03-APR-2020
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 27-MAR-2020 directing that "In view of the evolving situation with COVID-19, the parties are requested within the next ten (10) days to provide the Court with a status update for the proceeding including whether they anticipate meeting their upcoming deadlines in April and May and if not, their proposed timing for any amended dates. The Court notes that it is available to convene a case management telephone conference with the parties, including during the Suspension Period, if needed by the parties and all parties consent. If a case management conference is desired, the parties are requested to provide their joint availability." placed on file on 27-MAR-2020
Certified French language Translation of Reasons for Order and Order rendered on 23-DEC-2019 by Angela Furlanetto, Prothonotary filed on 10-FEB-2020 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Order entered in J. & O. Book, volume 1445 page(s) 88 - 90 and copy placed on file.
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 27-JAN-2020 directing that the court is in receipt of the plaintiff's letter dated 24-JAN-2020, sent on consent of the parties. A case management conference will not be needed at this time. The parties shall update the court further regarding the items noted in its letter in its status update to the court after discoveries. placed on file on 27-JAN-2020
Letter from Plaintiff dated 24-JAN-2020 "On January 24, 2020, the parties exchanged affidavits of documents. The parties do not anticipate any motions at this time and request to address the provision of claim charts and whether a dispute resolution would be appropriate after completion of examinations for discovery." received on 24-JAN-2020
Letter from Global Affairs Canada (Michelle Campbell, Deputy Director, Law Division) dated 16-DEC-2019 "I am writing to confirm that the law firm of McCarthy Tétrault LLP, on August 15, 2019, requested service of a Statement of Claim on the United States of America, in the matter referenced above, in accordance with Section 9 of the State Immunity Act. I enclose a certificate indicating that the Statement of Claim was transmitted to the United States Department of State on September 30, 2019." received on 23-DEC-2019
Solicitor's certificate of service on behalf of Marc Crandall confirming service of doc. #26 upon Plaintiff and Defendant by email on 07-JAN-2020 filed on 07-JAN-2020
Reply to Defence on behalf of Defendant/Patent Owner: USA as represented by the Secretary of Health Dept. Filed on 07-JAN-2020
Successful email transmission received from the parties with respect to order doc. 25 placed on file on 06-JAN-2020
Certificate of Order with respect to order and reasons dated 23-DEC-2019 (doc. 25) placed on file on 23-DEC-2019
Reasons and order dated 23-DEC-2019 rendered by Angela Furlanetto, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 15 Result: granted Filed on 23-DEC-2019 copies sent to parties Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1441 page(s) 24 - 25
Toronto 12-DEC-2019 BEFORE Angela Furlanetto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the court will render a decision on the reply pleading motion of U.S.A. in the absence of an agreement on the form and content of the pleading. held by way of Conference Call in chambers Duration per day: 12-DEC-2019 from 10:05 to 10:20 Courtroom : Judge's Chambers - Toronto Court Registrar: Jake Schutz Total Duration: 15min Appearances: Steven Tanner 416-601-8193 representing Plaintiff Harry Radomski and Richard Naiberg 416-602-3153 representing Defendant Christopher VanBarr and Marc Crandall 613-786-8675 representing defendant/patent owner United States of America Minutes of Hearing entered in Vol. 1037 page(s) 119 - 121 Abstract of Hearing placed on file
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 10-DEC-2019 directing that a case management teleconference shall take place on Thursday, December 12, 2019 at 10:00 a.m. for a duration of 30 minutes placed on file on 10-DEC-2019
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 06-DEC-2019 directing that the parties shall advise the court by close of business on 9-DEC-2019 whether they have reached a resolution regarding the patentee United States of America's motion to file a respnoding pleading, which was heard on 26-NOV-2019, and if so, the nature of such resolution, or whether the court should proceed with providing its decision on the motion. placed on file on 06-DEC-2019
Toronto 26-NOV-2019 BEFORE Angela Furlanetto, Prothonotary Language: E Before the Court: Motion Doc. No. 15 on behalf of defendant/patent owner United States of America Result of Hearing: Matter reserved held in Court Senior Usher: John Doherty Duration per day: 26-NOV-2019 from 14:02 to 15:03 Courtroom : Courtroom No. 4-A - Toronto Court Registrar: Jake Schutz Total Duration: 1h 1min Appearances: Christopher Van Barr 613-233-1781 representing defendant/patent owner United States of America Harry Radmomski and Richard Naiberg 416-979-2211 representing Plaintiff Comments: Matter record on Digital Audio Recording System Minutes of Hearing entered in Vol. 1036 page(s) 232 - 234 Abstract of Hearing placed on file
Solicitor's certificate of service on behalf of Belle Van confirming service of Doc. No. 23 and Book of Authorities upon Plaintiff by mail on 22-NOV-2019 filed on 22-NOV-2019
Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 22-NOV-2019
Motion Record in response to Motion Doc. No. 15 containing the following original document(s): 21 22 Number of copies received: 3 on behalf of Defendant filed on 22-NOV-2019
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 15 filed on 22-NOV-2019
Affidavit of Lisa Ebdon sworn on 22-NOV-2019 contained within a Motion Record on behalf of Defendant in opposition to Motion Doc. No. 15 with Exhibits "A"-"H" filed on 22-NOV-2019
Toronto 08-NOV-2019 BEFORE Angela Furlanetto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the motion will be heard 26-NOV-2019 starting at 2:00PM held by way of Conference Call Duration per day: 08-NOV-2019 from 10:00 to 10:15 Courtroom : Judge's Chambers - Toronto Court Registrar: Shaun Nelson Total Duration: 15min Appearances: Steven Tanner 416-601-8193 representing Plaintiff Herry Radomski 416-597-4142 representing Defendant Marc Crandall 613-783-8984 representing Counsel for US Government Minutes of Hearing entered in Vol. 1035 page(s) 388 - 389 Abstract of Hearing placed on file
Letter from Plaintiff dated 20-NOV-2019 "Allergan consents to the USA serving and filing a responding pleading in this action in accordance with the relief sought by the USA at paragraph 38 of its written representation. Unless requested by the Court, Allergan does not intend to submit any additional written representaiton or record other than this letter in respect of the within motion." received on 20-NOV-2019
Covering letter from Defendant dated 18-NOV-2019 concerning Authorities received on Nov. 18 2019 placed on file on 18-NOV-2019
Solicitor's certificate of service on behalf of Marc Crandall confirming service of Authorities Id: 42 upon Plaintiff Defendant by email on 15-NOV-2019 filed on 18-NOV-2019
Book of Authorities consisting of 1 volume(s) on behalf of The United States of America- Motion doc. no. 15 received on 18-NOV-2019
Memorandum to file from Amanda P dated 18-NOV-2019 Doc 15 sent to Toronto Local Office placed on file.
Covering letter from Defendant/Patent Owner (The United States of America) dated 15-NOV-2019 concerning Doc. No. 15 placed on file on 15-NOV-2019
Solicitor's certificate of service on behalf of Marc Crandall confirming service of Doc 15 upon Plaintiff Defendant by electronic mail on 15-NOV-2019 filed on 15-NOV-2019
Motion Record containing the following original document(s): 15 16 17 Number of copies received: 3 on behalf of Defendant/Patent Owner (United States of America) filed on 15-NOV-2019
Written Representations contained within a Motion Record on behalf of Defendant/Patent Owner (The United States of America) concerning Motion Doc. No. 15 filed on 15-NOV-2019
Affidavit of Susan Burkhardt sworn on 15-NOV-2019 contained within a Motion Record on behalf of Defendant/Patent Owner (The United States of America) in support of Motion Doc. No. 15 with Exhibits A to H filed on 15-NOV-2019
Notice of Motion contained within a Motion Record on behalf of Defendant/Patent Owner (United States of America) returnable at Special Sitting in Toronto on 26-NOV-2019 to begin at 14:00 for an Order (a) allowing the United States to serve and file a responding pleading in this action no earlier than sixty (60) days from the date of service of the Statement of Claim pursuant to the State Immunity Act; (b) allowing the United States' responding pleading to be in the form of a Reply to Apotex's Statement of Defence, or alternately, a direction from the Court pursuant to Rule 54 as to the appropriate form of pleading in the circumstance; filed on 15-NOV-2019
Solicitor's certificate of service on behalf of Marc Crandall confirming service of Notice of Consent to Electronic service upon Plaintiff by email on 13-NOV-2019 filed on 14-NOV-2019
Consent on behalf of Defendant/Patent Owner to Electronic Service filed on 14-NOV-2019
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 08-NOV-2019 directing that "Further to the case management conference convened on November 8, 2019, the patentee, United States of America's motion for leave to deliver a reply to the statement of defence shall be heard at a special sitting of the Federal Court in Toronto on November 26, 2019 at 2pm, for a durationnot to exceed two hours. The following timetable shall apply to the materials to be filed on the motion: 1)the patentee, United States of America's moving motion record shall be served and filed by November 15, 2019; 2)the plaintiff Allergan's responding motion record, if any shall be served and filed by November 20, 2019; 3)the defendant Apotex' responding motion record shall be served and filed by November 22, 2019." placed on file on 08-NOV-2019
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 07-NOV-2019 directing that a case management teleconference shall take place on Friday, November 8, 2019 at 10AM for a duration of 30 minutes placed on file on 07-NOV-2019
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 07-NOV-2019 directing that "The Court is in receipt of the letter dated November 4, 2019 from counsel for the patentee, United States of America, and the responding letter dated November 6,2019 from counsel for Apotex and November 7, 2019 from counsel for Allergan. As the patentee's request is not on consent and in consideration of the concerns raised in the letter from counsel for Apotex, a formal motion will need to be brought to address the patentee's request. Counsel shall be contacted by the Registry to provide their availability for a case managment conference to set a hearing date and timely schedule for such motion." placed on file on 07-NOV-2019
Letter from Plaintiff dated 07-NOV-2019 in response to the US Government's letter of November 4 and Apotex Inc.'s respondikngn letter of November 6, 2019 received on 07-NOV-2019
Letter from Defendant, Apotex Inc. dated 06-NOV-2019 re: in response to the unsolicited letter dated November 4,2019 from Gowlings WLG, solicitors for the Defendant, United States of America, as represented by the Secretary, Department of Health and Human Services received on 06-NOV-2019
Letter from the Patentee, United States of America dated 04-NOV-2019 requesting that the Court issue a direction permitting the USA to file a Reply to Defence by the later of 60 days from September 27, 2019, or 10 days after service of the Statement of Defence received on 05-NOV-2019
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 04-NOV-2019 directing that "Further to the letter dated October 31, 2019 from counsel for the plaintiff, the plaintiff shall provide the court with a further status update by November 15, 2019 along with dates and time when counsel are mutually available for a further case management conference if the Court determines that such a call is necessary." placed on file on 04-NOV-2019
Letter from Plaintiff dated 31-OCT-2019 providing an update on the issues set out in the Plaintiff's letter dated October 8, 2019 received on 01-NOV-2019
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 25-OCT-2019 directing that "The Plaintiff is requested to write to the Court by October 31, 2019 with an update regarding the issues set out in its October 8, 2019 letter." placed on file on 25-OCT-2019
Toronto 02-OCT-2019 BEFORE Angela Furlanetto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the will issue a scheduling order held by way of Conference Call Duration per day: 02-OCT-2019 from 03:00 to 03:35 Courtroom : Judge's Chambers - Toronto Court Registrar: Shaun Nelson Total Duration: 35min Appearances: Steven Tanner 416-601-8193 representing Plaintiff Andrew Brodkin 416-597-4278 representing Defendant Minutes of Hearing entered in Vol. 1032 page(s) 403 - 404 Abstract of Hearing placed on file
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 08-OCT-2019 directing that "The correspondence dated October 8, 2019 from counsel for the Plaintiff is noted. The Plaintiff shall provide the Court with a further update once the US Government's proposal has been discussed with the parties, including mutual dates of availability during the last week of October /first week of November for a case management conference. The Plaintiff shall also, at the same time, advise of any update regarding HRA Pharma." placed on file on 08-OCT-2019
Letter from Plaintiff dated 08-OCT-2019 re: update on service of the Statement of Claim upon the US Government and the scheduling of a case managment conference received on 08-OCT-2019
Acknowledgment of Receipt received from the Plaintiff and Defendant with respect to Doc. 12 placed on file on 07-OCT-2019
Order dated 07-OCT-2019 rendered by Angela Furlanetto, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1)The Trial of thise action shall take place at the Federal Court, 180 Queen Street W., in the City of Toronto, Ontario starting on Monday, the 3rd day of May, 2021, at 9:30 AM, for ten (10) sitting days. The ten days shall run from May 3-7, 2021, May 10-12, 2021 and May 20 and 21, 2021. 2)It shall be at the discretion of the Court to revisit the length of the trial should the scope of the proceedings. 3)The following timetable shall govern the next step in these proceedings: (PLEASE REFER TO ATTACHED ORDER) Filed on 07-OCT-2019 certified copies sent to parties entered in J. & O. Book, volume 1428 page(s) 156 - 159 Interlocutory Decision
Solicitor's certificate of service on behalf of Martin Brandsma confirming service of Doc. 10 upon Defendant (Apotex Inc.) by electronic mail (on consent) on 26-SEP-2019 filed on 26-SEP-2019
Reply on behalf of Plaintiff Filed on 26-SEP-2019
Letter from Plaintiff dated 27-SEP-2019 re: update regarding the status of the inventor-based document requests and whether the patentees will be taking an active role in the proceedings. received on 27-SEP-2019
Consent on behalf of Plaintiff and Defendant (Apotex Inc.) to electronic service of all documents that are not required to be personally served. filed on 26-SEP-2019
Toronto 16-SEP-2019 BEFORE Angela Furlanetto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: court to issue a direction with a timetable held by way of Conference Call Duration per day: 16-SEP-2019 from 02:00 to 02:20 Courtroom : Judge's Chambers - Toronto Court Registrar: Shaun Nelson Total Duration: 20min Appearances: Steven Tanner, Sanjaya Mendis, Martin Brandsna 416-601-8193 representing Plaintiff Andrew Brodkin 416-597-4278 representing Defendant Minutes of Hearing entered in Vol. 1031 page(s) 67 - 68 Abstract of Hearing placed on file
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 17-SEP-2019 directing that "Further to the case management conference convened on September 16, 2019, the Court directs as follows: by end of business day on September 27, 2019, the Plaintiff shall provide the Court with an update regarding the status of the inventor-based document requests and whether the patentees will be taking an active role in the proceedings. A further case management conference to discuss the timetable and trial date for the proceedings shall be convened on October 2, 2019 at 3pm" placed on file on 17-SEP-2019
Solicitor's certificate of service on behalf of Belle Van confirming service of doc. 7 upon Defendant by personal service on 16-SEP-2019 filed on 16-SEP-2019
Defence filed on 16-SEP-2019
Affidavit of service of Renee Tran sworn on 26-AUG-2019 on behalf of Defendant confirming service of doc. 5 upon Plaintiff by telecopier on 26-AUG-2019 filed on 26-AUG-2019
Notice of Intension to Respond filed on 26-AUG-2019
Acknowledgment of Receipt received from Defendant - HRA Pharma (via cover letter from Plaintif w/attached ack.) with respect to Doc 1 (Statement of Claim) filed on 23-AUG-2019
Oral directions received from the Court: Angela Furlanetto, Prothonotary dated 16-AUG-2019 directing that In accordance witht the Court's Guidelines, the plaintiff is reminded that it is required to submit, within 7 days of service of the Notice of Intention to Respond: 1) a jointly proposed timetable for the steps leading up to the trial of the action, having regard to the steps identified in the attached checklist, as applicable; 2) dates of mutual availability for the trial of this action, including the estimated duration, preferred venue and language for the trial; and 3) dates and times of mutual availability for a case management teleconference. As the defendant has not yet delivered its Notice of Intension to Respond, the plaintiff shall advise the defendant of this direction and provide a copy of the checklist upon being served witht he Notice of Intension to Respond. placed on file on 16-AUG-2019
Service copy of Statement of Claim with proof of service upon Defendant, Apotex Inc. on 15-AUG-2019 filed on 16-AUG-2019
Acknowledgment of Receipt received from the Plaintiff with respect to Order Doc. No. 2 placed on file on 15-AUG-2019
Order dated 15-AUG-2019 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 15-AUG-2019 re: Statement of Claim (PMNOC) Result: IT IS ORDERED pursuant to Rule 383 that Prothonotary Angela Furlanetto is assigned as Case Management Judge in this matter. Filed on 15-AUG-2019 copies sent to parties entered in J. & O. Book, volume 1422 page(s) 270 - 270 Interlocutory Decision
Communication to the Court from the Registry dated 14-AUG-2019 re: File sent to the Judicial Administrator for the appointment of a Case Management Judge
Letter from Plaintiff dated 14-AUG-2019 enclosing Statement of Claim pursuant to s.6(1) of the PMNOC Regulations, requesting case management, and indicating that the Plaintiff does not renounce the stay under para. 7(5)(b) of the Regulations. *scanned to Justice Manson* received on 14-AUG-2019
Statement of Claim filed on 14-AUG-2019 Tariff other action - $150.00
The official version of the court proceeding information is available from the court websites directly: